These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19370737)

  • 21. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
    Keck PE; Hsu HA; Papadakis K; Russo J
    Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tinnitus treatment with memantine.
    Figueiredo RR; Langguth B; Mello de Oliveira P; Aparecida de Azevedo A
    Otolaryngol Head Neck Surg; 2008 Apr; 138(4):492-6. PubMed ID: 18359360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
    Larsson V; Engedal K; Aarsland D; Wattmo C; Minthon L; Londos E
    Dement Geriatr Cogn Disord; 2011; 32(4):227-34. PubMed ID: 22122992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):369-74. PubMed ID: 19751915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.
    de Carvalho M; Pinto S; Costa J; Evangelista T; Ohana B; Pinto A
    Amyotroph Lateral Scler; 2010 Oct; 11(5):456-60. PubMed ID: 20565333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.
    Lindelof K; Bendtsen L
    Cephalalgia; 2009 Mar; 29(3):314-21. PubMed ID: 19220313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
    Gauthier S; Loft H; Cummings J
    Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memantine hydrochloride in the treatment of dementia subtypes.
    Peng D; Yuan X; Zhu R
    J Clin Neurosci; 2013 Nov; 20(11):1482-5. PubMed ID: 24035650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 30. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine: update on the current evidence.
    Möbius HJ
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S47-54. PubMed ID: 12973750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting usage patterns of memantine in Alzheimer disease.
    Lerner AJ; McClendon MJ; Sami SA; Ogrocki PK; Adams KB; Smyth KA
    Alzheimer Dis Assoc Disord; 2008; 22(2):137-43. PubMed ID: 18525285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
    Larsson V; Aarsland D; Ballard C; Minthon L; Londos E
    Int J Geriatr Psychiatry; 2010 Oct; 25(10):1030-8. PubMed ID: 20872929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
    Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
    Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease.
    Grossberg GT; Pejović V; Miller ML; Graham SM
    Dement Geriatr Cogn Disord; 2009; 27(2):164-72. PubMed ID: 19194105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Lazzeroni L; Rasgon NL
    Acta Neurol Scand; 2009 Mar; 119(3):172-9. PubMed ID: 18705678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating the full spectrum of dementia with memantine.
    Winblad B; Jelic V
    Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia.
    Leroi I; Atkinson R; Overshott R
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):899-905. PubMed ID: 24510471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.